Psychopharmacology Flashcards
1
Q
Antidepressants
A
- Increase serotonin (5HT) and/or noradrenaline (NA)
- Different antidepressants vary in:
- Effect on 5HT or NA
- Effects on other receptors
- Half-life, interactions and toxicity
2
Q
Selective Serotonin Reuptake Inhibitors (SSRIs)
A
- Fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram
- Usually 1st line
- Side effects:
- Gastrointestinal
- Common: Nausea, appetite loss, dry mouth, diarrhoea, constipation, dyspepsia.
- Uncommon: vomiting, weight loss.
- CNS
- Common: insomnia, dizziness, anxiety, fatigue, tremor and somnolence.
- Uncommon: EPS, seizures and mania.
- Other
- Common: sweating, delayed orgasm and anorgasmia.
- Uncommon: hyponatraemia and alopaecia.
- Gastrointestinal
- Fluoxetine has longest half-life and least discontinuation
- Sertraline used in people with lots of comorbidities
- Paroxetine has gretest risk of discontinuation, used in OCD
3
Q
Noradrenaline Reuptake Inhibitors (NARIs)
A
- Reboxetine
- Action - NA
- Less effective
4
Q
Tricyclic antidepressants (TCAs)
A
- Block 5HT and NA (as well as lots of other receptors)
- Very effective
- Lots of side effects
- Overdose dangerous and can cause seizures, coma and arrthymias
- SRI - depression lifts
- NRI - depression lifts
- H1 inserted - weight gain, drowsiness
- α inserted - dizziness, low BP
- M1 inserted - constipation, dry mouth, blurred vision, drowsiness
5
Q
Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs)
A
- Venlafaxine, Duloxetine
- Better tolerated than TCAs
- Possibly more effective than SSRIs for severe depression
- Used 2nd/3rd line
- Prominent side effect - sexual dysfuction
6
Q
Noradrenaline and specific antidepressants (NaSSAs)
A
- Mirtazepine
- Blocks α 2 receptors - Increases 5-HT release
- Blocks 5-HT2 and 3 receptors - anxiolytic effect
- Blocks H1 receptors - Sedation, Weight gain
- Relatively safe in overdose
- Used 2nd/3rd line
7
Q
Monoamine Oxidase Inhibitors (MAOIs)
A
- Inhibit monoamine oxidase
- A - NA, 5HT, DA, Tyramine
- B - DA, Tyramine, others
- Phenelzine, isocarboxazid, tranylcypromine (PIT) - inhibit MAOA and B irreversibly
- Moclobemide - inhibits MAOA reversibly
- Tyramine in the diet is a potential releaser of NA - NA broken down by MAOA in the brain and gut, if MAOA is inhibited then tyramine can lead to a hypertensive crisis
8
Q
Antipsychotics
A
- D2 + 5HT2a + HAM antagonism
- Dopamine receptor antagonism can effect 4 brain pathways:
- Mesolimbic (positive symptoms and reward - blockage causes anhedonia etc)
- Mesocortical (deficiency in dopamine leads to negative symptoms - worsen cognition)
- Nigrostriatal (extrapyramidal effects - Parkinsonism and tardive dyskinesia)
- Tuberoinfundibular (prolactin - galactorrhoea, infetility)
9
Q
Types of antipsychotics
A
- Typical/1st generation - mainly D2
- Chlorpromazine
- Flupentixol (Depixol)
- Haloperidol
- Sulpride
- Zuclopenthixol (Clopixol)
- Atypicals/2nd generation (QOAARC) - mixed D2 and 5HT2A effect so less EPSE and hyperprolactinaemia, more metabolic syndrome
- Quetiaprine
- Olanzapine
- Amisulpiride
- Aripiprazole
- Risperidone
- Clozapine (can cause agranulocytosis - fatal)
- Clozapine levels go up when patient stops smoking and side effects include sialorrhoea, seizures, myocarditis, agranulocytosis, sedation, constipation and sudden hyperglycaemia
- Monitoring includes weight, BP, ECG, glucose/HbA1c, lipids and remind patient to wear sunscreen
10
Q
Lithium
A
- Multiple mechanisms
- Narrow therapeutic index - monitor levels every 3 months
- Renal and thyroid dysfunction
- Renal function + TFTs 6 monthly, calcium annually
- Sudden discontinuation has 50% risk of mania
- Teratogenic - Ebstein’s anomaly
11
Q
Valproate (mood stabiliser)
A
- Multiple actions (including GABA)
- Not for women of child bearing potential - Teratogenicity (neural tube defects)
- Side effects include nausea, tiredness, weight gain, hair loss with curly regrowth
12
Q
Carbamazepine (mood stabiliser)
A
- Na channel blocker
- Side effects include nausea, headaches, dizziness, dry mouth, low WCC, raised LFT
13
Q
Lamotrigrine (mood stabiliser)
A
- Slow dose titration
- Risk of SJS
14
Q
Hypnotics/Anxiolytics
A
- Benzodiazepines
- GABA
- Diazepam, lorazepam, temazepam (-zepam)
- Tolerance after >4 weeks
- Z-drugs
- GABA
- Zopiclone, zolpidem
- Pregabalin - Ca channels
- Buspirone - 5HT1A agonist
- Propranolol, atenolol – beta blocker
- Antidepressants
- Sedative antipsychotics
15
Q
Aversive drugs
A
- Disulfiram (Antabuse) - aldehyde dehydrogenase inhibitor (alcohol > acetaldehyde (↑) > acetate)
- Acamprosate - alcohol cravings
- Opiate antagonists - Nalmefene – alcohol (reduced enjoyment), Naltrexone – opiate abuse